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Abstract 
 
Objective or Hypothesis The goal of this study was to examine the relationship between urinary incontinence and two 
conditions - respiratory symptoms and tobacco exposure - in a sample of smokers. It is hypothesized that increased 
respiratory symptoms and tobacco exposure would be associated with increased urinary incontinence. 
 
Population Men and women, ages 18-70, who smoked 10-40 cigarettes daily for the past year 
 
Methods Men and women, ages 18-70, who smoked 10-40 cigarettes daily for the past year, were recruited to participate 
in a smoking cessation study. At screening, participants reported smoking behavior history, urinary symptoms via two 
validated International Consultation on Incontinence Questionnaires (ICIQ), respiratory symptoms, medical history and 
demographics. Height and weight were obtained along with urine sample (for analysis of cotinine, a metabolite of nicotine 
and measure of tobacco exposure). Descriptive statistics and ANOVA/ANCOVAs, adjusting for sex, BMI, age, diuretics, 
and current health problems, were conducted using SAS 9.2.  
 
Main Results Participants (n=202) were, on average, 47.3±11.7 years old, 58% female, and smoked an average of 
19.3±7.3 cigarettes per day.  Compared to men and women with reported symptoms of stress incontinence (SI), those who 
reported no SI symptoms had significantly lower urinary cotinine values (5018.4±2433.6 ng/mL vs. 3753.8±2143.3 
ng/mL, respectively, p=0.004) and there was a trend indicating they may have a lower self-rated cough (4.5±2.4 vs. 
3.6±2.4, respectively, p=0.060). A trend was noted where those with no symptoms of urge incontinence had fewer pack-
years (28.5±15.6 vs. 31.0±19.3 p=0.060).  There was a sex by ICIQ score interaction, where men with no urinary 
symptoms had higher cotinine values compared to men with mild and moderate symptoms (4576.13±2201.9 vs. 
3900.7±2451.5 vs. 3776.6±2614.4, respectively); the same was not observed in women (3138.7±1731.6 vs. 
4777.3±2222.6 vs. 3437.7±2494.6; p=0.032).  
 
Conclusions There is an association between increased self-reported cough and urinary incontinence symptoms. Further, 
increased tobacco exposure, as defined by urinary cotinine, appears to be associated with stress incontinence symptoms 
while a more chronic tobacco exposure, as defined by pack-years, is associated with urge incontinence symptoms.  The 
sex difference with ICIQ score suggests that higher cotinine levels may affect men and women differently. More research 
is needed with a larger cohort to further explore the relationships between tobacco exposure, urinary symptoms, and 
respiratory symptoms. 
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